Prevalence and Risk Factors of Retinopathy of Prematurity in Premature Born Infants

Document Type : Original Article

Authors

1 Department of Pediatrics, School of Medicine, Clinical Research Development Unit, Kowsar Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

2 Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran

3 2. Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran 3. USERN Office, Qazvin University of Medical Sciences, Qazvin, Iran

4 School of Medicine, Clinical Research Development Unit, Kowsar Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

10.22038/ijn.2025.78159.2516

Abstract

Background: Retinopathy of prematurity (ROP) poses a serious challenge to the health of preterm infants. Given that blindness caused by this disease is treatable—and considering its higher incidence in developing countries—we investigated the prevalence and identified risk factors associated with ROP.
Methods: This cross-sectional study included 100 premature infants with a gestational age of less than 37 weeks and a birth weight of less than 2500 g. All infants were examined for ROP by an ophthalmologist beginning from the fourth postnatal week. Comparisons were made between two groups: those with ROP and those without.
Results: The prevalence of ROP in this study was 21%. The analysis showed a significant association between the occurrence of ROP and gestational age (P = 0.031), as well as the number of ventilator days (P = 0.05). However, no significant relationship was found between ROP occurrence and sex, age, birth weight, sepsis, oxygen therapy, Apgar score, intraventricular hemorrhage (IVH), pneumothorax, corticosteroid use, or surfactant administration (all
P > 0.05).
Conclusion: Preventive measures should be taken to reduce the incidence of premature deliveries. Additionally, clinicians should be aware of the increased risk of ROP when providing ventilation and adopt intelligent oxygen therapy and appropriate management strategies.

Keywords

References

  1. Singh JK, Wymore EM, Wagner BD, Thevarajah TS, Jung JL, Kinsella JP, et al. Relationship between severe bronchopulmonary dysplasia and severe retinopathy of prematurity in premature newborns. J AAPOS. 2019;23(4):209.e1-209.e4.
  2. Blencowe H, Moxon S, Gilbert C. Update on blindness due to retinopathy of prematurity globally and in India. Indian Pediatr. 2016;53 Suppl 2:S89-S92.
  3. Haghshenas Mojaveri M, Rasoulinejad S. The Relationship between Maternal and Neonatal Diseases and Retinopathy of Prematurity and Its Progression. J Babol Univ Med Sci. 2021;23(1):323-330.
  4. Fortes Filho JB, Eckert GU, Valiatti FB, Dos Santos PGB, da Costa MC, Procianoy RS. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2010;248(6):893-900.
  5. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singap. 2005;34(2):169-178.
  6. Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618-637.
  7. Naseh A, Dastjani-Farahani A, Yaghmaii B, Shariati MK, Taslimi-Taleghani N, Palizban-Kermanshahi F. Retinopathy screening of premature neonates born at gestational age 32-36 weeks. Iran J Neonatol. 2022;13(3).
  8. Shastry BS. Genetic susceptibility to advanced retinopathy of prematurity (ROP). J Biomed Sci. 2010;17(1):69.
  9. Feghhi M, Altayeb SM, Haghi F, Kasiri A, Farahi F, Dehdashtyan M, et al. Incidence of retinopathy of prematurity and risk factors in the South-Western region of Iran. Middle East Afr J Ophthalmol. 2012;19(1):101-106.
  10. Tan JB, Dunbar J, Hopper A, Wilson CG, Angeles DM. Differential effects of the retinopathy of prematurity exam on the physiology of premature infants. J Perinatol. 2019;39(5):708-716.
  11. Mueller B, Salchow D, Waffenschmidt E, Joussen A, Schmalisch G, Czernik C, et al. Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone. Br J Ophthalmol. 2017;101(3):365-370.
  12. Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131(1):189-195.
  13. Behnam Vashani H, Zeraati H, Rezaeian A, Abrishami M, Reyhani T, Shoeibi N. The effects of multi-sensory stimulation on the facial expression of neonates during eye examinations for retinopathy of prematurity screening. J Babol Univ Med Sci. 2015;17(5):19-24.
  14. Mutlu FM, Sarici SU. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol. 2013;6(2):228-236.
  15. Abrishami M, Maemori GA, Boskabadi H, Yaeghobi Z, Mafi-Nejad S, Abrishami M. Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iran. Iran Red Crescent Med J. 2013;15(3):229-233.
  16. Afarid M, Hosseini H, Abtahi B. Screening for retinopathy of prematurity in South of Iran. Middle East Afr J Ophthalmol. 2012;19(3):277-281.
  17. Bayat-Mokhtari M, Pishva N, Attarzadeh A, Hosseini H, Pourarian S. Incidence and risk factors of retinopathy of prematurity among preterm infants in Shiraz/Iran. Iran J Pediatr. 2010;20(3):303-307.
  18. Kadivar M, Ghalichi L, Mohammadi S, Mansouri M, Karkhaneh R, Mousavi S, et al. Incidence and risk factors of retinopathy of. Br J Ophthalmol. 2008;92:1446-1449.
  19. Khorshidifar M, Nikkhah H, Ramezani A, Entezari M, Daftarian N, Norouzi H, et al. Incidence and risk factors of retinopathy of prematurity and utility of the national screening criteria in a tertiary center in Iran. Int J Ophthalmol. 2019;12(8):1330-1336.
  20. Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol. 2009;148(3):451-458.
  21. Yau GSK, Lee JWY, Tam VTY, Yip S, Cheng E, Liu CCL, et al. Incidence and risk factors for retinopathy of prematurity in multiple gestations: A Chinese population study. Medicine (Baltimore). 2015; 94(18):e867.
  22. Binkhathlan A, Almahmoud L, Saleh M, Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol. 2008;92(2):167-169.
  23. Bowe T, Nyamai L, Ademola-Popoola D, Amphornphruet A, Anzures R, Cernichiaro-Espinosa LA, et al. The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela. Digit J Ophthalmol. 2019;25(4):49-58.
  24. Taqui AM, Syed R, Chaudhry TA, Ahmad K, Salat MS. Retinopathy of prematurity: frequency and risk factors in a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2008;58(4):186-190.
  25. Saeidi R, Taraghi B, Saeidi M. Incidence of retinopathy of prematurity (ROP) in low birth weight newborns. Iran J Neonatol. 2017;8(4):102-106.
  26. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity. a multivariate statistical analysis. Ophthalmologica. 2000;214(2):131-135.
  27. Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics. 2005;115(4):990-996.
  28. Enninga EAL, Nevala WK, Creedon DJ, Markovic SN, Holtan SG. Fetal sex‐based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol. 2015;73(3):251-262.
  29. Abdel HA, Mohamed G, Othman M. Retinopathy of prematurity: a study of incidence and risk factors in NICU of Al-Minya University Hospital in Egypt. J Clin Neonatol. 2012;1(2):76-81.
  30. Bas AY, Demirel N, Koc E, Isik DU, Hirfanoglu İM, Tunc T. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018;102(12):1711-1716.
  31. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993;100(2): 230-237.
  32. Dammann O. Inflammation and retinopathy of prematurity. Acta Paediatr. 2010;99(7):975-977.
  33. Akçakaya AA, Yaylali SA, Erbil HH, Sadigov F, Aybar A, Aydin N, et al. Screening for retinopathy of prematurity in a tertiary hospital in Istanbul: Incidence and risk factors. J Pediatr Ophthalmol Strabismus. 2012;49(1):21-25.
  34. Akkoyun I, Oto S, Yilmaz G, Gurakan B, Tarcan A, Anuk D, et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS. 2006;10(5):449-453.
  35. Al-Amro SA, Al-Kharfi TM, Thabit AA, Al-Mofada SM. Risk factors for acute retinopathy of prematurity. Ann Ophthalmol (Skokie). 2007;39(2):107-111.
  36. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med. 1992;326(16):1050-1054.
  37. Fetus AAoPCo, Newborn, Obstetricians ACo, Practice GCoO, Watterberg KL, Aucott S, et al. The apgar score. Pediatrics. 2015;136(4):819-822.
  38. Movsas TZ, Spitzer AR, Gewolb IH. Postnatal corticosteroids and risk of retinopathy of prematurity. J AAPOS. 2016;20(4):348-352. 
Iranian Journal of Neonatology
Volume 16, Issue 4
October 2025
Pages 37-42

Files

Share

How to cite

Statistics